Regeneron Pharmaceuticals (REGN)
Income Tax Expense
$837.30M
TTM · Period ending: · USD
REGN Income Tax Expense
Latest reported$837.30Mperiod ending
Latest reported$837.30Mperiod ending
REGN TTM Income Tax ($0.00 → $837.30M)
TTM income tax expense
High-resolution chart · PNG
REGN income tax expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Income Tax Expense (USD) |
|---|---|
| -2,649,000 | |
| 1,737,000 | |
| -28,000 | |
| -6,149,000 | |
| -3,347,000 | |
| -2,488,000 | |
| -1,000,000 | |
| -2,200,000 | |
| -4,300,000 | |
| -4,400,000 | |
| -3,500,000 | |
| -2,200,000 | |
| 1,500,000 | |
| 4,000,000 | |
| 7,500,000 | |
| 13,400,000 | |
| 20,600,000 | |
| 27,000,000 | |
| 29,400,000 | |
| 32,200,000 | |
| 32,600,000 | |
| 31,100,000 | |
| 29,000,000 | |
| 19,700,000 | |
| 10,800,000 | |
| 5,000,000 | |
| 1,500,000 | |
| 1,100,000 | |
| 1,100,000 | |
| -200,000 | |
| -400,000 | |
| -400,000 | |
| -500,000 | |
| 800,000 | |
| 800,000 | |
| 500,000 | |
| -3,100,000 | |
| -6,500,000 | |
| -6,600,000 | |
| -6,600,000 | |
| -3,200,000 | |
| 0 | |
| 0 |